Share on Pinterest A new trial finds that GLP-1 agonists may help reduce knee osteoarthritis-related pain. Westend61/Getty ...

Osteoarthritis, the most common form of arthritis, is primarily caused by wear and tear on the protective layer of cartilage ...

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss ...

“There are genetic aspects, physical aspects, and inflammatory aspects,” he says. Ozempic can help people to lose weight, ...

Novo Nordisk’s drug helped reduce knee pain in osteoarthritis patients with obesity. Meanwhile, the Change Healthcare breach ...

By Gina Kolata The blockbuster drug semaglutide, sold as Ozempic for diabetes and as Wegovy for weight loss, now has a new ...

Knee replacement surgeons may be inadvertently setting patients up for poor outcomes, according to a study that suggests a ...

Recent research has found that semaglutide injections, which also include controversial weight loss drug Ozempic, can reduce ...

Semaglutide shows promise in treating knee osteoarthritis by reducing pain and weight, offering a safe alternative to traditional pharmacological interventions.

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a ...

People who lost a significant amount of weight with semaglutide saw major improvements in osteoarthritis knee pain, research published Wednesday in the New England Journal of Medicine finds.